Search Within

Marc Ladanyi

  1. "Michael Berger"
Formats
  1. Meeting Abstract (114)
  2. Journal Article (100)
  3. Research Letter (5)
  4. Guidelines (1)
Groups
  1. Center for Molecular Imaging and Biotechnology (CMIB) (220)
  2. Department of Pathology and Laboratory Medicine (220)
  3. GSK Faculty (220)
  4. Human Oncology and Pathogenesis Program (220)
  5. Tow Center for Developmental Oncology (TCDO) (220)
  6. Department of Medicine (179)

More Groups

People
  1. Michael Berger (220)
  2. Ahmet Zehir (121)
  3. Maria Arcila (106)
  4. David Solit (99)
  5. Nikolaus Schultz (58)
  6. David Hyman (56)

More People

Years
  1. 2025 (6)
  2. 2024 (14)
  3. 2023 (13)
  4. 2022 (25)
  5. 2021 (12)
  6. 2020 (12)

More Years

Publications
  1. Journal of Clinical Oncology (36)
  2. Journal of Molecular Diagnostics (27)
  3. Cancer Research (18)
  4. Clinical Cancer Research (15)
  5. Modern Pathology (13)
  6. Cancer Discovery (11)

More Publications

Publishers
  1. American Association for Cancer Research (47)
  2. American Society of Clinical Oncology (43)
  3. Nature Publishing Group (32)
  4. Elsevier Science, Inc. (27)
  5. Nature Research (14)
  6. Elsevier Inc. (12)

More Publishers

Results (220)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Refining actionable HER2 alterations in lung cancers through next generation sequencing (NGS)
    Meeting Abstract

    Xu, C.; Myers, M.; Buonocore, D. J.; Razavi, P.; Shen, R.; Lai, W. C. V.; Smyth, L. M.; Zheng, T.; Ni, A.; Solit, D. B.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Prognostic relevance of tumor sequencing in metastatic lung adenocarcinomas
    Meeting Abstract

    Shen, R.; Martin, A.; Ni, A.; Hellmann, M. D.; Jordan, E.; Arora, A.; Ptashkin, R.; Zehir, A.; Kris, M. G.; Arbour, K. C.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Tumor mutation burden (TMB) and immune- related adverse events (irAEs) compared to antibiotic (abx) use to predict for response to immune checkpoint inhibitors in esophagogastric cancer (EGC)
    Meeting Abstract

    Greally, M.; Chatila, W. K.; Margolis, M.; Hechtman, J. F.; Tuvy, Y.; Kundra, R.; Ladanyi, M.; Kelsen, D. P.; Ilson, D. H.; Berger, M. F.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Comprehensive detection of targetable fusions in lung adenocarcinomas by complementary targeted DNAseq and RNAseq assays
    Meeting Abstract

    Benayed, R.; Offin, M. D.; Mullaney, K. A.; Sukhadia, P.; Rios, K. M.; Desmeules, P.; Chang, J. C.; Hyman, D. M.; Berger, M. F.; Zehir, A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Widespread somatic loss of heterozygosity as a possible marker of disease aggressiveness in metastatic well differentiated pancreatic neuroendocrine tumors
    Meeting Abstract

    Akala, O. O.; Shah, R.; Untch, B. R.; Kelly, V.; Chou, J. F.; Ladanyi, M.; Berger, M. F.; Klimstra, D. S.; Reidy, D. L.; Raj, N. P.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Real-time genomic characterization of metastatic pancreatic neuroendocrine tumors has prognostic implications and identifies potential germline actionability
    Journal Article

    Raj, N.; Shah, R.; Stadler, Z.; Mukherjee, S.; Chou, J.; Untch, B.; Li, J.; Kelly, V.; Osoba, M.; Saltz, L. B.; more...
    JCO Precision Oncology (2018)

    Fulltext@MSK | Save
  • Activating mutations in CSF1R and additional receptor tyrosine kinases in sporadic and familial histiocytic neoplasms
    Meeting Abstract

    Durham, B. H.; Lopez-Rodrigo, E.; Abramson, D. H.; Picarsic, J.; Pastore, A.; Mandelker, D.; Walsh, M. F.; Arcila, M. E.; Ladanyi, M.; Solit, D.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Clinical utility of prospective molecular characterization in advanced endometrial cancer
    Journal Article

    Soumerai, T. E.; Donoghue, M. T. A.; Bandlamudi, C.; Srinivasan, P.; Chang, M. T.; Zamarin, D.; Cadoo, K. A.; Grisham, R. N.; O'Cearbhaill, R. E.; Tew, W. P.; more...
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • Identification of viral integration sites in cancer genomes using unmapped reads in targeted next-generation sequencing data
    Meeting Abstract

    Bowman, A. S.; Middha, S.; Vanderbilt, C.; Ladanyi, M.; Berger, M.; Zehir, A.
    Journal of Molecular Diagnostics (2018)

    Fulltext@MSK | Save
  • Molecular epidemiology of CREBBP and EP300 mutations in solid tumors
    Meeting Abstract

    Solomon, J. P.; Gupta, S.; Zehir, A.; Berger, M. F.; Arcila, M. E.; Ladanyi, M.; Dogan, S.
    Journal of Molecular Diagnostics (2018)

    Fulltext@MSK | Save